Table 1.

Characteristics of PMR and silent GCA in PMR

PMR without GCA (n = 267)PMR with GCA (n = 79)PMR with isolated LV-GCA (n = 31)PMR with isolated cranial-GCA (n = 22)PMR with mixed-GCA (n = 26)
Age, years, mean (s.d.)72.86 (8.73)77.16 (8.27)75.45 (8.1)75.82 (8.9)80.34 (7.1)
Female sex, n (%)147 (55.1)32 (51.9)18 (58.1)11 (50)12 (46.2)
Hip pain, n (%)212 (79.4)77 (97.5)30 (96.8)22 (100)25 (96.2)
Neck pain, n (%)160 (59.9)44 (55.7)20 (64.5)11 (50)13 (50)
Morning stiffness presence, n (%)228 (85.4)63 (79.7)25 (80.6)16 (72.7)22 (84.6)
Weight loss, n (%)69 (25.8)18 (22.8)7 (22.6)2 (9.1)9 (34.6)
Fever, n (%)27 (10.1)8 (10.1)7 (22.6)0 (0)1 (3.8)
Peripheral arthritis, n (%)77 (29.1)24 (30.4)10 (32.3)6 (27.3)8 (30.8)
CRP, mg/l, mean (s.d.)52.23 (48.97)47.65 (47.85)48.37 (52.94)41.26 (46.44)51.71 (43.66)
ESR, mm/h, mean (s.d.)56.12 (28.24)57.75 (34.53)57.74 (33.25)60.84 (41.08)55.42 (31.87)
PMR without GCA (n = 267)PMR with GCA (n = 79)PMR with isolated LV-GCA (n = 31)PMR with isolated cranial-GCA (n = 22)PMR with mixed-GCA (n = 26)
Age, years, mean (s.d.)72.86 (8.73)77.16 (8.27)75.45 (8.1)75.82 (8.9)80.34 (7.1)
Female sex, n (%)147 (55.1)32 (51.9)18 (58.1)11 (50)12 (46.2)
Hip pain, n (%)212 (79.4)77 (97.5)30 (96.8)22 (100)25 (96.2)
Neck pain, n (%)160 (59.9)44 (55.7)20 (64.5)11 (50)13 (50)
Morning stiffness presence, n (%)228 (85.4)63 (79.7)25 (80.6)16 (72.7)22 (84.6)
Weight loss, n (%)69 (25.8)18 (22.8)7 (22.6)2 (9.1)9 (34.6)
Fever, n (%)27 (10.1)8 (10.1)7 (22.6)0 (0)1 (3.8)
Peripheral arthritis, n (%)77 (29.1)24 (30.4)10 (32.3)6 (27.3)8 (30.8)
CRP, mg/l, mean (s.d.)52.23 (48.97)47.65 (47.85)48.37 (52.94)41.26 (46.44)51.71 (43.66)
ESR, mm/h, mean (s.d.)56.12 (28.24)57.75 (34.53)57.74 (33.25)60.84 (41.08)55.42 (31.87)

LV: large vessel; n: number of cases.

Table 1.

Characteristics of PMR and silent GCA in PMR

PMR without GCA (n = 267)PMR with GCA (n = 79)PMR with isolated LV-GCA (n = 31)PMR with isolated cranial-GCA (n = 22)PMR with mixed-GCA (n = 26)
Age, years, mean (s.d.)72.86 (8.73)77.16 (8.27)75.45 (8.1)75.82 (8.9)80.34 (7.1)
Female sex, n (%)147 (55.1)32 (51.9)18 (58.1)11 (50)12 (46.2)
Hip pain, n (%)212 (79.4)77 (97.5)30 (96.8)22 (100)25 (96.2)
Neck pain, n (%)160 (59.9)44 (55.7)20 (64.5)11 (50)13 (50)
Morning stiffness presence, n (%)228 (85.4)63 (79.7)25 (80.6)16 (72.7)22 (84.6)
Weight loss, n (%)69 (25.8)18 (22.8)7 (22.6)2 (9.1)9 (34.6)
Fever, n (%)27 (10.1)8 (10.1)7 (22.6)0 (0)1 (3.8)
Peripheral arthritis, n (%)77 (29.1)24 (30.4)10 (32.3)6 (27.3)8 (30.8)
CRP, mg/l, mean (s.d.)52.23 (48.97)47.65 (47.85)48.37 (52.94)41.26 (46.44)51.71 (43.66)
ESR, mm/h, mean (s.d.)56.12 (28.24)57.75 (34.53)57.74 (33.25)60.84 (41.08)55.42 (31.87)
PMR without GCA (n = 267)PMR with GCA (n = 79)PMR with isolated LV-GCA (n = 31)PMR with isolated cranial-GCA (n = 22)PMR with mixed-GCA (n = 26)
Age, years, mean (s.d.)72.86 (8.73)77.16 (8.27)75.45 (8.1)75.82 (8.9)80.34 (7.1)
Female sex, n (%)147 (55.1)32 (51.9)18 (58.1)11 (50)12 (46.2)
Hip pain, n (%)212 (79.4)77 (97.5)30 (96.8)22 (100)25 (96.2)
Neck pain, n (%)160 (59.9)44 (55.7)20 (64.5)11 (50)13 (50)
Morning stiffness presence, n (%)228 (85.4)63 (79.7)25 (80.6)16 (72.7)22 (84.6)
Weight loss, n (%)69 (25.8)18 (22.8)7 (22.6)2 (9.1)9 (34.6)
Fever, n (%)27 (10.1)8 (10.1)7 (22.6)0 (0)1 (3.8)
Peripheral arthritis, n (%)77 (29.1)24 (30.4)10 (32.3)6 (27.3)8 (30.8)
CRP, mg/l, mean (s.d.)52.23 (48.97)47.65 (47.85)48.37 (52.94)41.26 (46.44)51.71 (43.66)
ESR, mm/h, mean (s.d.)56.12 (28.24)57.75 (34.53)57.74 (33.25)60.84 (41.08)55.42 (31.87)

LV: large vessel; n: number of cases.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close